Merritt Stevenson
Nurse Practitioner · West Columbia, SCNPI 1417297029
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 300 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by AbbVie at 43.2% of the total. 2025 is the largest year on record at $3,825, more than ten times the $277 reported in 2021. Among nurse practitioner clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 300 payments — averaging $25.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$710
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$615
- Madrigal Pharmaceuticals$327
- Medtronic$311
- Phathom Pharmaceuticals, Inc.$285
- plus $2K from 27 others
What the payments were for
- Food & beverage$7,739100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 155 | $3,341 |
| Johnson & Johnson | 11 | $710 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 21 | $615 |
| Madrigal Pharmaceuticals | 6 | $327 |
| Medtronic | 3 | $311 |
| Phathom Pharmaceuticals, Inc. | 5 | $285 |
| Lilly USA, LLC | 11 | $261 |
| Regeneron Healthcare Solutions, Inc. | 8 | $230 |
| Ardelyx, Inc. | 9 | $172 |
| Sanofi | 3 | $153 |
| Pfizer | 8 | $135 |
| Merck | 8 | $133 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $107 |
| Gilead | 6 | $99 |
| Aimmune Therapeutics, Inc. | 5 | $90 |
| Organon | 5 | $83 |
| Ferring Pharmaceuticals Inc. | 4 | $66 |
| Novo Nordisk | 3 | $58 |
| Fresenius Kabi USA, LLC | 3 | $57 |
| Nestle Healthcare Nutrition Inc. | 3 | $48 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
| Amarin Pharma, Inc. | 2 | $41 |
| QOL Medical, LLC | 1 | $37 |
| Bristol Myers Squibb | 2 | $29 |
| Acerus Pharmaceuticals Corporation | 1 | $24 |
| Amgen | 1 | $21 |
| Intercept Pharmaceuticals, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $19 |
| Mylan Institutional Inc. | 1 | $19 |
| AstraZeneca | 1 | $19 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,739 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 29 | $125,940 |
| ZenpepLipase/Protease/Amylase | 19 | $59,207 |
| XifaxanRifaximin | 18 | $53,887 |
| LinzessLinaclotide | 39 | $41,846 |
| IbsrelaTenapanor Hcl | 12 | $21,666 |
| Mesalamine | 20 | $12,335 |
| Dexlansoprazole DrDexlansoprazole | 25 | $10,323 |
| Pantoprazole Sodium | 354 | $5,126 |
| Colestipol Hcl | 57 | $2,886 |
| Esomeprazole Magnesium | 70 | $2,660 |
| Omeprazole | 128 | $2,234 |
| Colesevelam Hcl | 20 | $1,901 |
| Sucralfate | 68 | $1,783 |
| Dicyclomine Hcl | 100 | $1,677 |
| Famotidine | 113 | $1,571 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $3,341 | $167,78768 claims |
| Aimmune Therapeutics, Inc.Zenpep | $90 | $59,20719 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $615 | $53,88718 claims |
| Ardelyx, Inc.Ibsrela | $172 | $21,66612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.
Other nurse practitioner in West Columbia
- Margaret JohnsonWest Columbia$15K
- Janice MorrowWest Columbia$13K
- Mallory AndersonWest Columbia$7K
- David WiltGreenville$90K
- Whitney ReedCharleston$54K
- Mary JohnsonCharleston$34K
- Amanda HareCharleston$30K
- Kellie McLainCharleston$28K
- Colleen BoydSummerville$21K
- Mae BurtonGreenville$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.